ロード中...
Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017
Background: Dual antiplatelet therapy improves patient outcome after acute coronary syndrome (ACS), but prescription differences of P2Y12 inhibitor treatments exist. The aim of the present investigation was to study the long-term utilization and patient outcomes of clopidogrel, prasugrel, and ticagr...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690682/ https://ncbi.nlm.nih.gov/pubmed/33114045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113398 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|